Back

Select your region

Corporate

europe:

Flag Albania Albania Flag Bosnia and Herzegovina Bosnia and Herzegovina Flag Bulgaria Bulgaria Flag Croatia Croatia Flag Cyprus Cyprus Flag Montenegro Montenegro Flag Czech Republic Czech Republic Flag Denmark Denmark Flag Estonia Estonia Flag Spain Spain Flag Kosovo Kosovo Flag Lithuania Lithuania Flag Latvia Latvia Flag Luxembourg Luxembourg Flag Macedonia Macedonia Flag Germany Germany Flag Poland Poland Flag Portugal Portugal Flag Romania Romania Flag Serbia Serbia Flag Slovakia Slovakia Flag Slovenia Slovenia Flag Switzerland Switzerland Flag Sweden Sweden Flag Turkey Turkey Flag Hungary Hungary Flag United Kingdom United Kingdom Flag Italy Italy

Asia:

Flag UAE UAE Flag Hong Kong Hong Kong Flag Kuwait Kuwait Flag Lebanon Lebanon

Africa:

Flag South Africa South Africa

Schedule a cord blood consultation

Make an appointment

Contact us today!

Want to learn more about our services? Complete the form below and we will contact you as soon as possible to provide you with all the information you need and answer your questions.

    We kindly inform you that the personal data provided in the form will be processed by Polski Bank Komórek Macierzystych Sp. z o.o. ("PBKM") with its registered office in Warsaw, Al. Jana Pawła II 29 for telephone contact in connection with the provision of information on the service.

    Summary of patients treated

    Stem Cells
    Therapies

    Stem Cells Therapies

    The purpose of banking stem cells is to apply them in the therapy. For the first time cord blood was used in 1988 and since then according to publicly available statistics it has been used over 85 000 times worldwide (including statistics of China).

    FamiCord Group stores over 1,000,000 samples of cells of different types and has supplied stem cells for application in clinic for more than 7000 patients. We supply stem cells for standard transplantations (cord blood , bone marrow and mobilized peripheral blood) and cellular therapies. On top of that we provide cell based products in GMP standard for clinical trials.

    Stem cells manufactured in our premises helped patients with various diseases and therapeutic areas, including haematological, neurological, ophthalmological, orthopaedical, dermatological disorders.

    Check the full list of patients who received stem cell therapy derived from FamiCord labs.

    List last update: 06.2026

    List of patients who received stem cells from FamiCord Group laboratories

    List of patients who received stem cells from FamiCord Group laboratories
    Lp. Source Source type Diagnosis Medical field Year of application Therapy Country Age of recipient
    7201 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2017 Standard Therapy Poland 72
    7202 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2017 Standard Therapy Poland 60
    7203 Apheresis Allogeneic Chronic Myeloproliferative Neoplasm Blast Crisis Hematology 2017 Standard Therapy Poland 29
    7204 Apheresis Allogeneic Common Variable Immunodeficiency, Relapsed Hemophagocytic Syndrome Hematology 2017 Standard Therapy Poland 44
    7205 Apheresis Allogeneic Diffuse Large B-Cell Lymphoma Hematology 2017 Standard Therapy Poland 61
    7206 Apheresis Allogeneic Diffuse Large B-Cell Lymphoma Hematology 2017 Standard Therapy Germany 41
    7207 Apheresis Autologous Diffuse Large B-Cell Lymphoma – Relapse Hematology 2017 Standard Therapy Germany 67
    7208 Apheresis Autologous Follicular B-Cell Non-Hodgkin-Lymphoma Grade I-II Relapse Hematology 2017 Standard Therapy Germany 59
    7209 Apheresis Allogeneic Follicular Ca Hematology 2017 Standard Therapy Poland 42
    7210 Apheresis Autologous Follicular Lymphoma Hematology 2017 Standard Therapy Germany 47
    7211 Apheresis Allogeneic Hemophagocytosis Hematology 2017 Standard Therapy Poland 52
    7212 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 25
    7213 Apheresis Allogeneic Langerhans Lymphohistiocytosis Hematology 2017 Standard Therapy Poland 2
    7214 Apheresis Autologous Light-Chain Myeloma Hematology 2017 Standard Therapy Germany 62
    7215 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 58
    7216 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 63
    7217 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 61
    7218 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 64
    7219 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 59
    7220 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 68
    7221 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 50
    7222 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 56
    7223 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 62
    7224 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 53
    7225 Apheresis Allogeneic Morbus Hodgkin Hematology 2017 Standard Therapy Germany 38
    7226 Apheresis Autologous Morbus Hodgkin Hematology 2017 Standard Therapy Germany 60
    7227 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 61
    7228 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 65
    7229 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 64
    7230 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 61
    7231 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 60
    7232 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 58
    7233 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 61
    7234 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 63
    7235 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 58
    7236 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 72
    7237 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 63
    7238 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 50
    7239 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 52
    7240 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 72
    7241 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 57
    7242 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 56
    7243 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 59
    7244 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 64
    7245 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 72
    7246 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 69
    7247 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 52
    7248 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 67
    7249 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 64
    7250 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 64
    7251 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 50
    7252 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 67
    7253 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 53
    7254 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 62
    7255 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 44
    7256 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 62
    7257 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 56
    7258 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 60
    7259 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 64
    7260 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 64
    7261 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 60
    7262 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 3
    7263 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 56
    7264 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 54
    7265 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 75
    7266 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 64
    7267 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 64
    7268 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 46
    7269 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 53
    7270 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 71
    7271 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 50
    7272 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 63
    7273 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 67
    7274 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 65
    7275 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 68
    7276 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 59
    7277 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 63
    7278 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 69
    7279 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 54
    7280 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 65
    7281 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 63
    7282 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 54
    7283 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 49
    7284 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 39
    7285 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 67
    7286 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 69
    7287 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 76
    7288 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 70
    7289 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 53
    7290 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 69
    7291 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 63
    7292 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 66
    7293 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 68
    7294 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 63
    7295 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 61
    7296 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 61
    7297 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 22
    7298 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 40
    7299 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 57
    7300 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 63